Buprenorphine/Naloxone
Buprenorphine/Naloxone is a pharmaceutical drug with 63 clinical trials. Currently 6 active trials ongoing. Historical success rate of 82.2%.
Success Metrics
Based on 37 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
14
Mid Stage
29
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.2%
37 of 52 finished
28.8%
15 ended early
6
trials recruiting
63
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients
Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
Low-dose Buprenorphine Initiation for Opioid Use Disorder
Low-dose Versus a High-dose Sublingual Buprenorphine Induction
Clinical Trials (63)
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients
Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
Low-dose Buprenorphine Initiation for Opioid Use Disorder
Low-dose Versus a High-dose Sublingual Buprenorphine Induction
Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder
Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder
A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
Rapid Initiation of Drug Treatment Engagement
Novel Induction to Buprenorphine/Naloxone
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
Buprenorphine Induction for Fentanyl Dependent Opioid Users
Effect of Heroin Use on Immune Activation and Cardiovascular Risk in HIV
Dane County Drug Court Study for Addicted Offenders
Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study
Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing
Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 63